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Platelet factor 4
(PF4), which is released by platelets
during coagulation, binds very tightly to negatively
charged oligosaccharides such as heparin. To date, six
other proteins are known that are homologous in sequence with PF4 but have quite different functions.
The structure of a tetramer of bovine PF4 complexed
yith one Ni(CN);- moleculehas been determined at 3.0
A resolution and refined to an R factor of 0.28. The
current model contains residues24-85, no solvent, and
one overall temperaturefactor. Residues 1-13, which
carried an oligosaccharide chain, were removed with
elastase to induce crystallization; residues 14-23 and
presumably 86-88 are disordered in the electron
density map. Because no heavy atom derivative was isomorphous with the native crystals, the
complex of PF4
with one Ni(CN):- molecule was solved using a single,
highly isomorphous Pt(CN)z- derivative and theiterative, single isomorphous replacement method.
The secondary structure of the PF4 subunit, from
amino- to carboxyl-terminal end, consists of an extended loop, three strands of antiparallel @-sheetarranged in a Greek key, and one a-helix. The tetramer
containstwoextended,six-stranded
@-sheets, each
formed by two subunits, which are arrangedback-toback to form a “@-bilayer”structure with two buried
salt bridges sandwiched in the middle. The carboxylterminal a-helices, which contain lysine residues that
are thought to be intimately involved in binding heparin, are arranged as antiparallel pairs
on the surface
of each extended @-sheet.

et al., 1977). Thehumanand
bovine sequences are 73%
identical.
When released into the plasma from activated platelets,
PF4 attractswhite blood cells, i.e. neutrophils andmonocytes,
and its release may be the signal that initiates inflammation
(Deuel et al., 1981). Other possible functions of PF4 derive
from its strongbinding to negatively charged polysaccharides,
especially heparan andheparin, for which it has a dissociation
constant of 10-7.5(Loscalzo et al., 1985). The ability of PF4
to neutralize heparin and related polymers is of general interest because heparin has been shown to interact with over 50
enzymes (Machovich, 1984), to suppress smooth muscle
growth (Castellot et al., 1982), and to accelerate angiogenesis
in solid tumors (Taylor andFolkman, 1982).PF4 hasrecently
been patentedas“Oncostatin A for its ability toinhibit
tumor growth (Twardzik and Todaro, 1987). It also has been
shown to reverse immunosuppression in mice (Katz et al.,
1986).
Platelet factor 4 also binds tightly and preferentially to
double-stranded DNA in vitro.’ This binding probably does
not occur in vivo, but it might be an important attribute of
several recently discovered, growth-related proteins that are
homologous to PF4. Members of this class are 1) induced by
y-interferon (Luster et al., 1985), 2) constitutively overexpressed in transformed Chinese hamster and humancell lines
(Anisowicz et al., 1987), 3) strongly induced by Rous sarcoma
virus in fibroblast cell lines (Sugano et al., 1987; Bedard et al.,
1987),and 4) overexpressed in stimulated leukocytes (Schmid
and Weissmann, 1987; Walz et al., 1987; Yoshimura et al.,
1987).
Another homolog of PF4 that has been known for some
time in the human platelet system is P-thromboglobulin and
Platelet factor 4 (PF4)l is carried within the a-granules of its two precursors, platelet basic protein (Holt et al., 1986)
platelets in the form ona noncovalent complex with a proteo- and low affinity platelet factor 4 (Rucinski et al., 1979),which
glycan carrier (Barber et al., 1972). PF4 is a tetramer (Bock is also named connective tissue activating protein I11 (Castor
et al., 1980) of four identical polypeptide chains, each of which et al., 1983). Collectively, these proteinsappear to be involved
contains 88 residues (Mr = 9580) in the bovinemolecule
in inflammation and wound healing (Senior et al., 1983).
(Ciaglowski et al., 1986) or 70 residues in the human (Deuel
When released by activated platelets during coagulation,
et al., 1977; Hermodson et al., 1977; Morgan et al., 1977; Walz PF4 displaces thrombin from the heparan on the surface of
* This work wassupported by National Institutesof Health Grants endothelial cells, wherethrombin is anticoagulant through its
GM33912, HL 27073, and RR 02945, and grants-in-aid from the accelerated interactions with antithrombin I11 (AT-III),
American Heart Association of Michigan, and the Wayne State thrombomodulin, and protein C, into solution, where thromUniversity Center for Molecular Biology. The costs of publication of bin is procoagulant through its interactions with fibrinogen
this article were defrayed in part by the payment of page charges. and other clotting factors (Stern et al., 1985; Loscalzo et a/.,
This article must therefore be hereby marked “aduerttsement” in 1985). It also prevents the formation of the ternary complexes
accordance with 18 U.S.C. Section 1734 solelyto indicate this fact.
between heparin, AT-111, and various procoagulant serine
$Recipient of a predoctoral Traineeship T32 HL 07602from
proteases that are intermediate in the heparin-accelerated
National Heart, Lung and Blood Institute.
To whom reprint requests should be addressed Dept. of Biochem- inhibition of proteases byAT-I11 (Rosenberg and Damus,
istry, Wayne State University, 540 E. Canfield Ave., Detroit, MI 1973; Laurent et al., 1978).
48201.
The strongest binding between heparin and PF4 requires
The abbreviations used are: PF4, platelet factor 4; AT-111, anti- heparin molecules above 10,000 daltons in size or approxi-

thrombin III; HLA-A2, human class I histocompatibility antigen form
A2; ISIR, iterative single isomorphous replacement; p-TG, P-thromboglobulin.
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mately 16 saccharide units (Luscombe and Holbrook, 1983;
Denton et al., 1983). Luscombe and Holbrook (1983) postulated that the critical size arises from the heparin winding
around the outside of a globular protein core. From small
angle neutron scattering experiments (Ibel et al.,1986), they
were able to calculate a radius of 2.11 nm for the PF4 core
and an average radius of 2.5 nm for the heparin coiled around
the core.
A similar model has also been developed from x-ray diffraction data byCowan et al. (1986). They used the packing
density of human PF4 crystals (Kurachi, 1978; Machin and
Isaacs, 1984) and a rotation functionconfirming 222 symmetry in the PF4 tetramer todeduce a model in which the PF4
core, represented as four tetrahedrally arranged spheres of
radius 1.6 nm, had an overall radius of3.6 nm. Using this
method, they proposed that a 16-saccharide heparin coil with
a radius of 1.7 nm could reach all four heparin binding sites
on the PF4 tetramer. Although these models are undoubtedly
correct in their overall concepts, theyare based on very
limited structural information. In $his paper we present a
refined model of bovine PF4 at 3.0 A resolution.
MATERIALS ANDMETHODS

Preparation of PF4 Crystals-Platelet factor 4 was purified from
bovine platelets as described by Ciaglowski et al. (1981); it was
crystallized in space group P212121with a = 63.7 A, b = 66.7 A, c =
80.5 A, and a tetramer of 32,000 daltons in the asymmetric unit, as
described by St. Charles et al. (1984) with the modification that the
protein was treated with porcine elastase prior to crystallization.
After the initial report was published, we discovered that thefirst 13
amino acids, which included an oligosaccharide, must be removed
from the amino-terminal end of bovine PF4 before it will crystallize.
An endogenous, contaminating protease removed these residues in
our original crystallizations; however, we have found that porcine
elastase will also catalyze the conversion with the advantage that it
is faster and more controllable.
On this basis, PF4 could be reproducibly crystallized as follows. A
10-20 mg/ml solution of PF4 in 50 mM Tris, pH 8.0, was prepared
and treated with porcine elastase (1:1000, w/w) for 0.5 h at 25 “C.
The insoluble suspension was spun at 1200 X g for 30 s and the
resulting oily pellet washed with several volumes of cold, 50 mM Tris
buffer, pH 8.0. The pellet was dissolved in enough 0.4 M NaC1, 50
mM Tris-HC1, pH 8.0, to give a final protein concentration of 10 mg/
ml. This solution was setupina
hanging drop or nested dish
arrangement (5-20 ql) andallowed to vapor-equilibrate against 0.020.14 M NaCl. Crystals 0.5 X 0.5 X 1.0 mm in size wereobtained within
1-2 weeks. They were stored in a stabilizing buffer of 20 mM Tris,
pH 8.0.
Data Collection-Diffraction data were collected to 3.0 A resolution
on two crystals for both the nickel and platinum derivatives (Table
I). Theintensities were measured on a Nicolet/Syntex P2, four circle

Crystal“

TABLEI
Diffraction data
Limits Total* Used’

A

R,,

Decay

Rmwe

Nickel 1
10-3.6 4103 4028 0.051 0.15
Nickel 2
3.8-3.0 3653 3454 0.039 0.16
Nickel0.044
merged
6912 709610-3.0
Platinum 1
10-3.6 4098
3986
0.040
0.28
3.8-3.0 3671
3474
0.036
0.18
Platinum 2
Platinum merged7080
10-3.0
6901
0.047
“Nickel” is elastase-treated bovine PF4 reacted with K2Ni(CN)r;
“platinum” is elastase-treatedbovine PF4 reacted with K2Pt(CN),.
Total relections possible within the resolution limits.
e Number of reflections with an intensity greater than twice the
standard deviation.
dRBym
=
I I Fi I - I F k I I /,E I F; I summed over all symmetry equivalent pairs of reflections L and k.
e Rmr, =
I I; - < I > k I 1 <I>, I summed over all i data sets
for all k reflections used. <I>k is the average intensity for reflection
k.

/x

diffractometer, which had been modified for protein data collection
with an extended detector arm and a 385-mm-long, helium-filled
beam tunnel. The w scan of the reflection, which wastaken over 0.33”
at 0.66”/min, was broken into 11 steps, of which the best seven were
kept for the intensity measurement. The nickel-filtered, copper K, xrays were generated at 40 kV, 25 mA. Crystals were mounted in glass
capillaries with the long axis of the crystal, which was parallel to the
crystallographic a-axis, aligned along the spindle axis.
The intensity data were processed using the PROTSYS package
of crystallographic programs implemented on a VAX 11/780 computer. Individual backgrounds were not collected. Instead, an empirical correction was calculated as a function of 20 and d, (Krieger et
al., 1974). This approach saves significant time in the data collection
and gives R,, values for protein data that are equal or better than
those from the traditional method. Radiation damage was corrected
from a linear least squares analysis of four monitor reflections. The
absorption correction was calculated by the method of North et al.
(1968) from measurements on two strong axial reflections (hOO)
collected over a 180” range in d, in 15” increments.
For each derivative, the data were collected from 10 to 3.6 and 3.8
to 3.0 8, on two crystals. Scaling and merging of the partial data sets
was done with the DIFCOR program in the ROCKS suite of crystallographic programs (Reeke, 1984) using the overlapping 3.6-3.8 A
data together with 10-2.9 A Okl data which were also collected on
each crystal.
Determination of the Phases-An exhaustive search for heavy atom
derivatives, over a period of 2 years, failed to identify any heavy atom
reagents that would produce site-specific derivatives isomorphous
with the native crystals. Crystals of PF4 were found to be quite fragile
and susceptible to cracking upon exposure to submillimolar concentrations of heavy atom salts. However, potassium platinum tetracyanide (K2Pt(CN),-3H2O)generated an excellent, albeit nonisomorphous derivative, as evidenced by a regular fracture pattern in the
crystals, by precession photographs showing a larger unit cell, and by
the retention of the high angle intensities. The unit cell axes a, b,
and c were, respectively, 0.16, 1.45, and 0.25 A longer than those of
the native crystals. These observations offered the possibility that a
light atom analog could be used to prepare parent crystals isomorphous with the platinum derivative. An isomorphous parent “derivative” was prepared by treating native crystals with the chemically
analogous complex, potassium nickel tetracyanide (KZNi(CN),). In
both cases, derivatization was accomplished by slow diffusion of the
complex over a 2-day period. The crystals were placed in 200 pl of
stabilizing buffer in a microdialysis cell and floated on top of 5 ml of
stabilizing buffer containing 0.2 mM reagent. The dialysis cell was
prepared from a 1.5-ml Eppendorf centrifuge tube. The center was
removed from the cap, the tube below the upper rim was cut off, and
dialysis membrane was then clamped between the cap and the rim.
Patterson maps based on the differences in diffraction intensities
and anomalous scattering between platinum and nickel derivatives
indicated a single site of substitution. It was used to calculate initial
phases for the nickel derivative as the “native” from the equations
for single isomorphous replacement. These phases were then refined
by the iterative method of Wang (1985).
Electron Density Fitting-The main chain of the four monomers
in the crystallographic asymmetric unit were fit independently. Then
the noncrystallographic symmetry transformation between the monomer with the best overall electron density (monomer A) and the
other three subunits were calculated by least squares methods from
the positions of equivalent mainchain C, atoms. Side chains for
monomer A were then fitinto the density. Since the monomers
appeared to be very similar, we rotated and translated the completed
A-monomer into thedensity for the other three monomers. No major
adjustments in the side chains of the other monomers were necessary
before refinement started. During refinement we examined regions
that had a questionable fit with 2F0 F, electron density maps. As a
final check of the model, we stepped through the entire sequence of
the tetramer in 24 consecutive “fragment-deleted maps. The segment
in question, usually 11 residues, was removed from the model, five
cycles of restrained least squares (Hendrickson and Konnert, 1980)
were run, and then a 2F, - F, electron density map was calculated.
Refinement-The model was
refinedby restrained least squares
(Hendrickson and Konnert, 1980) in two stages. In the first stage the
restraints were chosen to make the four subunits equivalent, residues
75-85 an ideal helix, and thetorsion angle x 3 of the cystines equal to
90”. Theweighting factors were those recommended by Hendrickson (1985). In the second stage the subunits were independent,
residues 75-85 were partially constrained to be helical, andthe
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cystines were as in stage 1. Due to the modestresolution of the
diffraction data, individual temperature factors and solvent were not

included.

RESULTS

Themeanfractional
isomorphousdifference was 13.2%
between the nickel and platinum data sets. Fig. 1 shows the
Harker sections from the isomorphous difference Patterson
mapcalculatedusing
I FR - F N ~I as coefficients inthe
synthesis. The single, well defined peak indicated one major
0.064, 0.024, and
bindingsitewithfractionalcoordinates
0.229, respectively, forx , y, and z. Early electron density maps
phased with this solution
were left-handed so the coordinates
were inverted for subsequent calculations. This site was also
observed in an anomalousdifference Patterson synthesis using anomalous difference data measured on the K2Pt(CN)4
derivative (data not shown). The occupancy and positional
parameters of the single heavy atom sitewere refined by fullmatrix least squares. The final R factor, using 10-3.0 A data
and simpledifference data, was 0.54 after 12 cycles of refineFIG.2. ISIR electron density map of the amino terminus.
ment.
The starting model for refinement of residues Cys-25 to Asn-35 is
The mean figure of merit of the initial,single isomorphous superimposed on the electron densitymap that was calculated at 3.0
replacement phase set was 0.34. The phases were refined by A resolution from the nickel derivative data and the ISIR phases.
the iterative single isomorphous replacement (ISIR) method
(Wang, 1985). Asolvent maskwa! prepared from the starting
SIR phases using all data to3.0 A. This mask was then used
for electron density filtering and phase refinement for four
cycles. A second mask was calculated based on the refined
0

a
FIG.3. Final fragment-deleted electron density map of the
amino terminus. Residues Gln-24 to Asn-35 from the refined model
of PF4 ( R = 0.28) are superimposed on a 2F. - F, electron density
map. The map wascalculated after fivecycles of restrained least
squares refinement that did not include Gln-24 to Ile-34.

FIG.1. Patterson maps calculated from the intensity differences between the nickel and platinum data sets. The three
Harker sectionsfor space group P212121(a)U = 0.5, ( b ) V = 0.5, and
( c ) W = 0.5 are shown with the first contour line representing 20%
of the origin peak and each succeeding contour line representing an
increment of 10%. Data between 10 and 4.2 A were used in the
calculation.

phases and the original SIR phases were refined using the
secondmask.After calculating a third solvent mask from
these phases, the
original phases were subjected to eightcycles
of phase refinement resulting ina final mean figure of merit
of 0.78. In effect, the 32,000-dalton PF4 structurewas phased
using a single, 50-electron heavy atom derivative.
In the original ISIR-phased map, we fit residues 25-85 of
all four subunits by first fitting thewell defined, main chain
electron density in all
four subunits. Transformation matrices
among the subunits were calculated by least squares superposition of these individually fit pieces of main chain. We
in the Athen fit the side chains and entire main chain
subunit. Stretches of weaker electron density in the A-subunit, which were primarily in the amino-terminal
region, were
fit by comparison with equivalent but better defined regions
in one or more of the other subunits.Fig. 2 shows our initial
model for the amino terminus region of subunit A superimposed on the ISIR electrondensity.Theamino-terminal

Structure of Bovine
Factor
Platelet

FIG. 4. Final fragment-deleted electron density map of the
carboxyl terminus. Residues Gln-70 to Gly-85 from the refined

model of PF4 ( R = 0.28) are superimposed on a 2F, - F, electron
density map. The map was calculated after five cycles of restrained
least squares refinement that did not include the residues Tyr-75 to
Gly-85.

section had the weakest density in all four subunits. The
complete A-subunit was then rotated intothe electron density
of the other threesubunits using the transformation matices.
After several false starts using the restrained least squares
refinement program, we reduced the R factor from 0.49 to
0.28 in 50 cycleswith an error of 0.019 in thebond lengths.
In the early stages of the refinement we were able to locate
Gln-24 in a 2F0 - F, electron density map. Fig. 3 shows the
final model for the amino-terminal region displayed in Fig. 2.
Fig. 4 shows the final model for the carboxyl-terminal region
of subunit A. Fig. 5 shows the entire C,-backbone of the AB
dimer after refinement. Different views of the C,-backbone
for all four subunits plus the side chains of selected residues
are shown in Figs. 6 and 7. The final electron density map
contained density for 62of the 75 residues present in the
elastase-treated PF4 (Asp-14 through Ser-88). No convincing
electron density was seen for 10 residues on the aminoterminalend (Asp-14 through Gln-23) nor for thelast3
residues on the carboxyl-terminal end. By contrast, the disulfide bonds Cys-25 to Cys-51 and Cys-27 to Cys-67were
especially clear in the map.

A

DISCUSSION

For convenience in this discussion, we labeled as “A” the
subunit that we fit in its entirety by manual methods, its
partner in the extended @-sheetas “B,” its nearest neighbor
in the opposite @-sheet as“C,” and its farthestneighbor “D.”

FIG. 5. The PF4 dimer. The a-carbon backbone of residues 24-85 (subunit
A) and residues 124-185 (subunit B)
from the refined model ofPF4 are shown
in stereo. The view is approximately
down the AB noncrystallographic 2-fold
axis. The positions of the C, atoms are
marked with small circles. The two cystine bonds near the amino-terminal end
of each subunit are drawnwith thin lines
between the side chain atoms and large
circles for the sulfur atoms.

4
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Residues 24-85 refer to monomer-A, which is used as the
representative subunit of the PF4 tetramer because it interacts least with the nickel ion. Residues 124-185,224-285, and
324-385 belong to subunits B, C, and D, respectively. Also,
we have divided the tetramer into two nominal dimers consisting of the AB and CD monomers based on the presumed
strength of the interactions among the subunits. There is no
evidence for dimers existing independently in solution.
The major elements of secondary structure in thePF4
subunit, which are shown in stereo in Fig. 5 and diagrammatically in Fig. 8, are a 12-residue loop, three strands of antiparallel @-sheet, and a 12-residue helix. The helix, which is
on the “outside” of the molecule, crosses the pleated sheet at
an angle of approximately 52”. These elements place PF4
among the a + @ class of protein structures (Creighton, 1984).
The four subunits in the crystallographic asymmetric unit are
paired to form two extended @-pleatedsheets of six strands
each (Fig. 5) which are then arranged back-to-back (Fig. 6)
to form a tetramer. At physiological ionic strengths, human
PF4 exhibits the molecular weight characteristic of a tetramer
(Kaser-Glanzmann et al., 1972; Bocket al., 1980).
The PF4 tetramerin this p s t a l structure hasapproximate
+mensions of 35 x 35 X 45 A and a radius of gryation of 18.4
A. Ibel et al. (1986) derived a value of 17.4 A from neutron
scattering experiments. The difference is probably due to a
small expansion in the PF4 structure caused by the nickel
ion. The symmetry of the four subunits isapproximately 222,
as expected, but it is distorted by the binding of the nickel
ion between tetramers. The tetramer is far from being pseudotetrahedral as shown by the fact that the putative heparin
binding sites are clearly grouped in pairs; the helices in the
same dimer are separated by approximately 14 A while*those
in different dimers are separatedby approximately 36 A. The
tetramer is packed along the b-axis in the crystal with the
basic carboxyl-terminal helices of its subunits next to the
acidic amino-terminal endsof subunits in adjacent tetramers.
The structure of PF4 is unusual. The most similar structure
is that of the a1 and a2domains of the class I histocompatibility antigen, HLA-A2 (Bjorkman et al., 1987). However,
HLA-A2 differs from PF4 dimer in having an eight-stranded
@-sheet,longer helices, and a greater separation between the
helices. The widest separation between C, atoms of the two
helices in HLA-A2 (1HLA jn the Brookhaven Protein Data
Bank) is approximately 14 A, which is wide enoygh to bind a
peptide. The separation is approximately 10 A in PF4. In
addition, the helices in HLA-A2 cross the @-sheetat anangle
of approximately -45” instead of the +52” found in PF4
dimers. Despite these differences the related motifs of the two
proteins are provocative given that PF4 stimulates the immune system (Katz et al., 1986). Sheet structures that extend
across subunits also occur in dimers of prealbumin (Blake et
al., 1974), concanavalin A (Reeke et al., 1975), alcohol dehy-
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FIG. 6. The PF4 tetramer withselected side chains. The a-carbonbackbone from the refined model of the
PF4 tetramer is shown in stereo as viewed approximately down the AC noncrystallographic 2-fold axis. The AB
dimer is drawn with darkerlines. Side chainsfor the residues involved in the internal salt bonds (Glu-43 and
Lys65 in each monomer) areshown as connected dots; for the four lysines on the carboxyl-terminalhelix (Lys-76, -77,
-80, -81 in each monomer) the side chains are shown as line segments.

FIG. 7. The PF4 tetramer and the nickelposition. The a-carbon backbone from the refined model of the
PF4 tetramer is shown in stereo, as viewed approximately down the AD noncrystallographic 2-fold axis. The
position of Tyr-75 in each monomer hasbeen labeled to identify the monomers. Hollow circles mark the positions
dots for the
of the two nickel atoms that are shared with adjacent tetramers. Side chains are drawnconnected
as
residues involved in the internal salt bonds (Glu-43 and Lys-65 in each monomer).

drogenase (Eklund et al., 1976), and aspartate transcarbam- namely Glu-143/Lys-365 and Glu-343/Lys-16?, which have
Glu-OE1 to Lys-NZ distances
of 9.65 and 8.67 A, respectively,
ylase R-chain (Krause etal., 1987).
Secondary Structure-Residues Glu-1 t o Leu-23 are miss- are presumably not made in this particular crystal form due
to distortion by the nickel substitution.
ing due to proteolyticremoval and disorder. The first 13
Residues Ala-47 to Ser-53form ahairpin loop (Sibanda and
residues were removed with elastase prior to crystallization.
The other 10 missing residues are unobserved, possibly be- Thornton, 1985) between strands I and I1of the /3-sheet.
involving a hydrogen bond
cause they include 5 acidic residues which repulse one another There is an atypical 14-atom turn
so stronglyin the low ionic strengthenvironment of the from Gly-48 to Cys-51. Residues Pro-54 to Thr-59 and Argcrystals (20 mM Tris), that theylocally denature the protein. 64 to Leu-68 form strands I1 and 111, respectively, of the pWe know that the 10 residues are present because Edman sheet. They are linked by residues Lys-60 to Gly-63, which
sequencing of PF4 fromawashed
and redissolved crystal form a hydrogen-bonded reverse turn. In the rat (Doi et al.,
confirmed the amino-terminal sequence from Asp-14 to Gln- 1987) and human3 genes for PF4, an intron occurs between
residues 57and 58 instrand 11. Thereare two p-bulges
24.
Residues Gln-24 to Ile-34 are best described as being ran- (Richardson, 1981); a wide type a t Ile-39/Ser-40 anda G type
dom coil or as forming a large,open loop. There are bends, as at Gly-63/Arg-64.
Residues Gln-70 to Leu-74 loop between strand I11 and a
defined by Kabsch and Sander(1983), centered at residues 25
and 27 and one hydrogen bond from Thr-31 toCys-67 in the helix at the end of the molecule. There is a hydrogen bond
alsostabilized by the two between Gln-70 and Arg-72 which forms an inverse y-turn
&sheet (Fig. 8). Thechainis
disulfide bonds Cys-25 to Cys-51 andCys-27 to Cys-67. Res- (Rose etal., 1985). ResiduesTyr-75 toGly-85 form an a-helix
idues Asn-35to His-38form an externalloop that is stabilized that lies diagonally across the top of the @-sheet. Since the
axis of the helix follows the slope from the saddle point
of the
by a main chain hydrogen bond (38N + 350). It does not sheet rather than the
rise, this packing arrangementfalls into
reverse the direction of the polypeptide chain and could be class 2 of Chou etal. (1985) rather than class 4. Although the
viewed as a single turn of helix.
former is less favored energeticallyin theoretical calculations,
Residues Ile-39 to Ser-46, which comprise strand I of the the difference is less for antiparallel @-sheets than
for parallel
three-stranded p-sheet in the monomer, also form six main ones.
chain hydrogen bonds (Fig. 8) with the adjacent monomer in
The secondary structure that we observe for residues 24the extended p-sheet. Leu-42 and Val-44 contact the hydro- 85 of bovine PF4 differs significantly from that predictedby
phobic surface of the carboxyl-terminal helix. Glu-43 on the the Chou and Fasman algorithm (Lawler, 1981) for human
“interior side” of the &sheet inmonomer A forms an internal PF4, which should have essentially the same
overall structure
salt bridge with Lys-265 of monomer C in the other extended as the bovine protein, We observe 18% a-helix, 29% p-sheet,
@-sheet and
similarly for the related pair
Glu-243/Lys-65. The 19% reverse turn, and 34% unordered coil, whereas the prerespective Glu-OE1 to Lys-NZ distances are2.77 and 3.22 A.
M. Poncz, personal communication.
The comparable salt bridges between monomers B and D,
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Tertiary and Quaternary Interactions-Along with the intrachain disulfide and hydrogen bonds, there areseveral clusters of hydrophobic residues whichcontribute significantly to
I
024
I
I
the integrity of the monomer structure. Residues Ile-34 and
C25
I
TIF
Pro-36 at the end of the random coil form a cluster with
residues Ile-39, Ile-66,and Leu-68in the 6-sheet andresidues
G48
V26
P52
Leu-74 and Ile-78 in the a-helix. At the helix-sheet interface
I
I
I
residues Leu-42, Val-44, and Leu-56 in the 0-sheet are toA47
s53
gether with residues Tyr-75, Leu-79, and Leu-83 in the aI
I
I
L28
a70
G46
P54
W S 1 4 0
P73
helix.
I
I
I
I
I
The A/B dimer is maintained by six hydrogen bonds (Fig.
145
SI41
L74
055K29
069
8)
and by the cluster of hydrophobic residues at the helixI
I
I
I
sheet interface which extends into the adjacent monomer to
V 4 4 X L 1 4 2
L56
T30
includeresiduesLeu-142,
Val-144, Leu-156, Tyr-175,LeuI
I
I
I
..
E143
E43
L57
C67
T31
179, and Leu-183. Only 3 of the 12 residues in subunit B that
I
I
I
I
are within 3.5 8, of a residue in subunit A are hydrophilic.
142 z V 1 4 4
A58
532
Theinner hydrophobicsurfaces of thea-helices actually
I
I
I
I
overlap the @-sheet strands from the adjacent monomer. A
1145
S41
T59
G33
I
consequence of these interactions is that the shallow groove
I
I
I \
S40G146
L79
R64
K60
134
between the two helices, which has a floor defined by Leu-42,
I
I
I
I /
Val-44, Pro-54, Leu-56, and the equivalent
residues in subunit
139
K80
G63
B,
and
walls
defined
by
residues
Gln-70,
Tyr-75,
Leu-79, LeuI
I
83, and the equivalent residues in subunit B, is quite hydroK81
T62
HB1
phobic.
Hydrophobic interactions are also evident at the interface
of the A/B and C/Ddimers. Residue Val-26 at the beginning
P36
of the long stretch of random coil and residues Ile-45 and
I
Leu-57 in the @-sheet cluster with the equivalent
residues in
N35
D84
I
subunit C. However, the interface between the two dimers,
G85
which contains thefour buried salt linksdiscussed previously,
appears to be predominantly hydrophilic.Sevcn of the 10
FIG.8. Hydrogen bonds andtopology of PF4. The four loops, residues in subunitsC and D that are within
3.5 A of a residue
three strands of @-sheet, and one a-helix found in the
PF4 monomer in subunit A are hydrophilic.
are indicated in a diagram of the topology of the monomer. The two
Additional evidence for the structural significance of these
cystine bonds are shown as shaded lines. The main chain hydrogen
bonds, as determined by the graphic display program QUANTA, are interactions comes from the conservation of specific residues
shown by arrows going from the donor to the acceptor. The criteria in the sequences of proteins that are homologous to PF4. As
for a hydrogen bond are that the angles C=O. . .H,
0 . . .H-N, and
shown in Fig. 9, the salt link between positions 43 and 65 is
H-I-C be greater than go”, and that the distance N.
. .O not exceed conserved in the sequences of all proteins homologous to PF4
3.3 A for a “short” hydrogen bond and 4.0 for a “long” one (Baker
with the sole exception of the human GRO protein. In the
and Hubbard, 1984). A hydrogen bond was included in the diagram
if it was present in allfour subunits andwas a short bond ina t least Chinese hamster GRO protein, protein 9-E3, and protein 3one of them. Exceptions to these criteria are the bonds S41 -+ T59 lOC, the acidic and basic residues have switched positions in
and D84 -+ K80 which were long in all the subunits, andR72 -+ Q70 the sequence. In protein 3-10C, lysine is replaced by arginine
which was short in subunits A and D but absent in subunits B and a t position 43. Also, in almost all the homologs, hydrophobic
C, which instead had a long hydrogen bond toD69. Several hydrogen residues occupy the same 12 positions identifiedabove as
bonds within thehelix, namely K80 + K77, K81- 178, D84 -+ K80,
and G85 -+ K81,which were short in a t least one subunit, were not having important structural roles in PF4. Hydrophilic residues occuronce at position 66 and 74 and four times at
included because they were missing in other subunits.
position 83.
Nickel Site-The structures of the four subunits in the
dicted structure is 55% a-helix, 18% @-sheet, 26% reverse
crystallographic
asymmetric unit are quitesimilar; the largest
turn, and 1%unordered coil. The predicted structure for the
large open loop is a strand of @-sheet anda reverse turn; for root mean square deviation between main chain coordinates
the short, external loop, another reverse turn; for strand I, is 0.69 A for subunits A and D. The tetramer, however, is
helix; for strand 11, helix; for strand 111, @-sheet and helix; significantly asymmetric. Its distortionfrom 222 symmetry in
and for the y-reverse turn,
helix. The reverse turns atresidues the structure reported here is caused by the Ni(CN2- ions,
b-axis of the crystals
47-50 and 61-63 arepredicted correctly t o within a few which insert between tetramers along the
residues, as is the carboxyl-terminal helix. Furthermore, the and increase the axisby 1.45 A. The @-bilayeris pried open
prediction that thefour lysines implicated in binding heparin along the BD edge by approximately 5 8, measured between
would be clustered on one side of a helix is verified in our the amino termini of the two subunits. Four residues have
non-carbon atoms within 6 A of the two nickel sites that
structure.
An exact comparisonbetween the distributionof secondary bracket each tetramer, namely, Cys-325 and Gln-324 (N) in
structure in ourmodel and that measuredby circular dichro- subunit B and Lys-181 and Lys-177 in subunit D. Lys-181, in
ism on human PF4 (Villanueva et al., 1988), namely 15% a - particular, seems to make a specific contact (NZ to Ni is2.19
helix, 25% @-structure, and 60% unordered
coil, is notpossible A). Although the tetramer, which occupies one asymmetric
because the first 10 residues are disordered in our crystals.
unit, is not under a crystallographic constraint to have 222
However, taken atface value,the circulardichroism measure- symmetry, itis unlikely that asymmetric crystal packing alone
ments imply that these 10residues are neither a-helix nor@- could cause the substantial distortionsdiscussed above.
sheet.
Heparin Binding Site-The positively charged amino acid
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FIG. 9. Sequences of PF4 and its homologs. The sequences of bovine (Ciaglowski et al., 1986), human
(Poncz et al., 1987), and rat PF4 (Doi et al., 1987) are compared along with those of six homologous proteins,
Luster et al.,
namely human 0-thromboglobulin (H-bTG Holt et al., 1986), y-interferon induced protein (IP-10;
1985), Chinese hamster and human growth-related proteins (CHEF GRO, HUMN GRO;Anisowicz et aL, 1987),
Rous sarcoma virus-induced protein (9-E3;Sugano et al., 1987), and mitogen-stimulated human leukocyte protein
(3-IOC; Schmid and Weissmann, 1987). The positions are numbered according to the bovine PF4 sequence with
letters for insertions. Protein 9-E3 was also reported as pCHEF-4 with leucine replacing phenylalanine a t position
5 (Bedard et al., 1987). Protein 3-1OC was also reported as neutrophil-activating factor by Walz et al. (1987) and
monocyte-derivedneutrophil chemotactic factor by Yoshimura et al. (1987).The alignments with the PF4sequence
are taken from the original papers; residues identical with those in PF4 are in boldface. The known or putative
amino-terminal residue of the mature protein is boxed for each sequence. For human P-TG, the amino-terminal
serine of platelet basic protein (Holt et al., 1986), the amino-terminal asparagine of low affinity platelet factor 4
(Rucinski et al., 1979) or connective tissue-activating protein I11 (Castor et nl., 1983) and the amino-terminal
glycine of P-TG (Begg et al., 1978) are indicated. Dots indicate exon-intron boundaries in the rat (Doi et al., 1987)
and human3PF4 genes.

side chains, especially the cluster of four lysines (Lys-76, -77,
-80, -81) near the carboxyl-terminal end, are of paramount
importance in binding heparin (Handin and Cohen, 1976).
The refined positions of the four lysine side chains areshown
in Fig. 4 and 6. Lysine side chains, which are usually on the
surface and highlymobile, are often disordered in crystal
structures. In Fig. 4, some electron density, albeit discontinuous, is seen for all four lysine side chains. The side chain of
Lys-81 is the best ordered of the four. The lysines are bunched
on the side of the helix that is opposite to the helix of the
neighboring monomer (Fig. 6). Lawler (1981) showed that the
spacing of the four lysines in the PF4 sequence would put
them together on one side of the helix that he had predicted
for the carboxyl-terminal end of PF4. p-Thromboglobulin, a
proteolyzed derivative of platelet basic protein, has a lower
affinity for heparin than does PF4. Lawler (1981)pointed out
that the extra residue (Gln-79a in Fig. 9) between the pairs
of lysine residues in @-TGwould create a staggered rather
than in-line arrangement of the lysines. Our model of PF4
predicts that one of the lysines in /3-TG, either 76 or 81, is
buried between the carboxyl-terminal helix and the@-sheet.
To our knowledge, no other three-dimensional structure of
a heparin-binding protein is known. In a similar fashion to
Lawler's analysis of the PF4 sequence, Villaneuva (1984) has
proposed a model of the heparin binding site in AT-I11 based
on prediction of secondary structure and chemical modifica-

tion experiments. A helix containing lysines 282,286, and 299
would have the three positive charges on the same side and
optimally arranged to interact with three critical sulfates on
the octasaccharide binding unit in heparin that is preferred
by AT-111.
In the absence of a structure of the heparin-PF4 complex,
we can only speculate as tohow the complex might be formed.
The negatively charged heparin has been shown to wrap
around the outside of the PF4tetramer (Ibel et al., 1986) and
to interact specifically with lysine residues. Handinand
Cohen (1976) showed that guanidination, which changes the
structure but not the charge of the lysines, greatly reduced
the binding of heparin while modifications to the arginine
residues had no effect. A preliminary analysis suggests two
possible structures for the heparin complex. The polysaccharide chain could pass along the shallow hydrophobic groove
between the two helices of each dimer or it could cross-over
the helices moreor less at right angles. The latterroute would
follow a belt of positively charged residues around the PF4
tetramer. However, heparin binding to PF4, which is not a
very cationic protein (PI = 7.6; Handin and Cohen, 19761,
need not be entirely electrostatic, as shown by related experiments on antithrombin. Although heparin binds specifically
to lysine residues on antithrombin (Rosenberg and Damus,
1973),the overall interaction is nonelectrostatic (Heuck et al.,
1985) and also involves specific tryptophan residues in anti-
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